| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 04/13/2006 | DE102005045848A1 New chromane and chromene derivatives useful as components in liquid crystalline media and in liquid crystal display element or electrooptical display element |
| 04/12/2006 | EP1358183B1 Cysteine protease inhibitors |
| 04/12/2006 | EP1345920B1 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/12/2006 | EP1254119B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 04/12/2006 | CN1250543C Heterocyclic substituted 2, 5-pyrroline photochromic copmounds and synthesis and use thereof |
| 04/11/2006 | US7026491 E.g., dimethylcarbamic acid, 2-oxo-3-benzyl-4-methyl-2H-1-benzopyran; affects both the Tumor Necrosis Factor alpha level and transcription activity of NuclearFactor kappa Beta; antiimmunoinflammatory agents and autoimmune properties; antiarthritis agents; rheummatic diseases; osteoporosis; leukemia |
| 04/11/2006 | US7026487 Amines substituted with a dihydronaphthalenyl, chromenyl, or thiochromenyl group, a pyridyl group and an alkyl group, having retinoid-like biological activity |
| 04/11/2006 | US7026357 Diphenylurea compounds |
| 04/11/2006 | US7026352 Physiologically active substances |
| 04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/06/2006 | WO2006034833A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/06/2006 | WO2006034804A1 Indozolone derivatives as 11b-hsd1 inhibitors |
| 04/06/2006 | WO2005049532A3 A process for purification |
| 04/06/2006 | US20060074243 Hydroxamic acid and amide compounds and their use as protease inhibitors |
| 04/06/2006 | US20060074123 Cyclic AMP-specific phosphodiesterase inhibitors |
| 04/06/2006 | US20060074112 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/06/2006 | CA2581375A1 Specific kinase inhibitors |
| 04/06/2006 | CA2577185A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 04/05/2006 | EP1642895A2 Novel substituted naphthopyrans |
| 04/05/2006 | EP1642571A2 Method for preparing submicron particle suspensions |
| 04/05/2006 | CN1249051C Muscarinic agonists |
| 04/05/2006 | CN1249043C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/04/2006 | US7022696 Treatment of airway disorders |
| 04/04/2006 | CA2132134C Benzofuran-2-ones as stabilisers |
| 03/29/2006 | EP1638570A1 Pyrimidine derivatives as cannabinoid receptor ligands |
| 03/29/2006 | CN1753898A Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof |
| 03/29/2006 | CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753666A Halogenated triptolide derivatives as immunomodulators and anticancer agents |
| 03/29/2006 | CN1247542C Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 03/29/2006 | CN1247541C Cyclic imines as pesticides |
| 03/28/2006 | CA2244862C Substituted amide derivatives |
| 03/28/2006 | CA2153805C C10 taxane derivatives and pharmaceutical compositions |
| 03/23/2006 | WO2006031782A2 Salvinorin derivatives as opioid receptor ligands |
| 03/23/2006 | WO2006030960A1 Photocationic curable composition and new compound |
| 03/23/2006 | WO2006030032A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/23/2006 | CA2581144A1 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 03/22/2006 | EP1637527A1 Cannabinoid receptor modulator |
| 03/22/2006 | EP1637518A2 Inhibitors of aspartyl protease |
| 03/22/2006 | EP1636204A1 ESTERS OF FLAVONOIDS WITH w-SUBSTITUTED C6-C22 FATTY ACIDS |
| 03/22/2006 | EP0962456B1 Cyclic ketone derivative and pharmaceutical use thereof |
| 03/22/2006 | CN1751031A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1751030A HIV replication inhibiting pyrimidines and triazines |
| 03/22/2006 | CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 03/21/2006 | CA2147854C Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them |
| 03/21/2006 | CA2134625C Substituted pyridylsalicylaldehyde or -salicylic acid derivatives, their preparation and their use as herbicides |
| 03/16/2006 | WO2005113535A3 Pyrazinylmethyl lactam derivatives |
| 03/16/2006 | WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 03/16/2006 | WO2005095378A3 Vegetable based dioxanone derivatives, synthesis and uses thereof |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058246 Macrolide compounds endowed with antiinflammatory activity |
| 03/16/2006 | DE102004040014A1 New aureonitrile compounds useful as cytostatic agents, fungicides and antibiotics |
| 03/15/2006 | EP1633733A1 Cannabinoid derivatives, methods of making, and use thereof |
| 03/15/2006 | EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists |
| 03/15/2006 | CN1747936A Substituted azole derivatives as therapeutic agents |
| 03/14/2006 | US7012093 Multiple fluorescent natural dye compound from a marine organism and method of use thereof |
| 03/14/2006 | US7012088 Indolone oxazolidinones and derivatives thereof |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2147984C Butenyl-substituted taxanes and composition |
| 03/09/2006 | WO2006025070A2 Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol |
| 03/09/2006 | US20060052439 Salvinorin derivatives and uses thereof |
| 03/09/2006 | US20060052358 Modulators of ATP-binding cassette transporters |
| 03/09/2006 | DE4344422B4 Pyri(mi)din-Derivate und flüssigkristallines Medium Pyri (mi) dine derivatives and liquid crystalline medium |
| 03/09/2006 | CA2579078A1 Cyclopamine analogues and methods of use thereof |
| 03/08/2006 | EP1631562A1 Chromene derivatives as anti-inflammatory agents |
| 03/08/2006 | EP1631561A2 Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| 03/08/2006 | EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof |
| 03/08/2006 | EP1347747B1 Method for preparing submicron particle suspensions of pharmaceutical agents |
| 03/08/2006 | EP1318995B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/08/2006 | EP0948327B1 Antidiabetic agents |
| 03/08/2006 | CN1745070A 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors |
| 03/08/2006 | CN1244578C Substituted benzofuran-2-carboxamides derivatives |
| 03/08/2006 | CN1244569C C-10 position taxane derivative and its medicine composition |
| 03/07/2006 | US7008952 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 03/07/2006 | US7008948 Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors |
| 03/02/2006 | CA2577191A1 4-heteroarylmethyl substituted phthalazinone derivatives |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | CN1742008A Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them |
| 03/01/2006 | CN1742007A Indole-derivative modulators of steroid hormone nuclear receptors |
| 03/01/2006 | CN1740171A Second order non-linear optical chromophore containing indolyl radical and its prepn and application |
| 03/01/2006 | CN1243746C Heterocyclic compound inhibiting angiogenesis |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2006 | CA2204204C Carbohydrate derivatives |
| 02/23/2006 | US20060041138 Process for producing paroxetine hydrochloride hydrate |
| 02/23/2006 | US20060041132 Novel triazolo pyrimidine compounds |
| 02/23/2006 | US20060040990 Epothilone derivatives, process for their production, and their pharmaceutical use |
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1626966A1 Benzofuran inhibitors of factor viia |
| 02/22/2006 | EP1626720A1 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors |
| 02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 02/21/2006 | US7002022 treatment of neoplastic diseases that respond to inhibition of the vascular endothelial growth factor receptor tyrosine kinase activity; tumors, retinopathy, macular degeneration |
| 02/21/2006 | US7001620 Kavalactone product |
| 02/21/2006 | CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors |
| 02/21/2006 | CA2250258C Novel tetralone or benzopyranone derivatives and process for producing the same |
| 02/16/2006 | WO2006015860A2 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |
| 02/16/2006 | WO2005079378A3 Synthetic techniques and intermediates for polyhydroxy dienyl lactones and mimics thereof |
| 02/16/2006 | US20060036092 making 4(R)-[-2,6-diamino-purin-9-yl)-[1,3]-dioxolan-2(R)-yl]-methanol ( beta -D-DAPD); esterification, cyclization, selective reduction, purification |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | DE102004034913A1 Neue Verbindungen, die Faktor Xa-Aktivität inhibieren Novel compounds which inhibit factor Xa activity |
| 02/16/2006 | CA2572752A1 Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor |